Sophie Parmentier Batteur

Company: Biogen

Job title: VP, head of Neuromuscular Diseases Research Unit

Seminars:

Panel Discussion: Evaluating Current Strategies for ALS Target Identification: What are the Avenues to Still Prioritise? 11:15 am

• Outlining current avenues of disease pathology to identify and validate targets for familial and sporadic ALS • Processing disease pathology information to validate genetic ALS targets • Where are the current innovations for novel target identification?Read more

day: Day One AM